Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - CHANGE IN WORKING CAPITAL
Change in Working Capital EBS - Emergent BioSolutions Inc.
-70.3 M
LAST VALUE
32.96%
2 YEAR CAGR
10.01%
5 YEAR CAGR
-14.61%
10 YEAR CAGR